March 12, 2018 / 11:46 AM / 9 months ago

BRIEF-TAE Life Sciences To Develop Groundbreaking Therapy For Difficult-To-Treat Cancers; Announces $40 Mln Series A Funding

March 12 (Reuters) -

* TAE LIFE SCIENCES TO DEVELOP GROUNDBREAKING THERAPY FOR DIFFICULT-TO-TREAT CANCERS, INCLUDING HEAD, NECK AND GBM; ANNOUNCES $40 MILLION SERIES A FUNDING

* TAE LIFE SCIENCES - ‍PARTNERSHIP WITH NEUBORON MEDTECH; TO DELIVER NEUTRON BEAM SYSTEM TO NEUBORON FOR FIRST INSTALLATION IN MEDICAL APPLICATION​ Source text for Eikon:

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below